Observation of a Bone Invasion Model of Aspergillus fumigatus In Vitro and Analysis of the Antifungal Susceptibility

被引:0
|
作者
Shao, Yan [1 ]
Shen, Min [2 ]
Peng, Dan [2 ]
Cheng, Wenxu [2 ]
Mao, Chenggang [2 ]
Zhang, Heng [3 ]
Sun, Yi [3 ]
机构
[1] Yangtze Univ, Dept Orthoped, Jingzhou Hosp, Jingzhou, Hubei, Peoples R China
[2] Yangtze Univ, Jingzhou Hosp, Dept Otolaryngol Head & Neck Surg, Jingzhou, Hubei, Peoples R China
[3] Yangtze Univ, Jingzhou Hosp, Dept Neurosurg, Jingzhou 434020, Hubei, Peoples R China
关键词
Aspergillus fumigatus; Osteolytic; Invasive; Fungal infection; Antifungal drug; FUNGAL SINUSITIS; DIAGNOSIS;
D O I
10.1007/s11046-023-00817-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Recently, the prevalence of invasive fungal infections has been on the rise, and one of the prevalent symptoms frequently observed is bone deterioration and bone loss.Materials and Methods Using an in vitro model we studied how Aspergillus fumigatus invades the bone. Pathological analysis was then employed to observe the structure and distinctive features of the invading fungal elements within the bone invasion model. Meanwhile, the antifungal effects of itraconazole, voriconazole, posaconazole, and amphotericin B were evaluated.Results The pathological findings showed that in the experimental group, fungal spores and hyphae invaded the bone tissue or were observed growing in the vicinity of the bone edge tissues, as indicated by both HE and PAS staining. In contrast, no fungal elements were observed in the control group, indicating that the in vitro bone invasion model of A. fumigatus was successfully constructed. Furthermore, the findings from the antifungal sensitivity test demonstrated that the lowest effective concentrations of antifungal drugs against the bone invasion model were as follows: 4 mu g/ml for itraconazole, 0.5 mu g/ml for voriconazole, 2 mu g/ml for posaconazole, and 2 mu g/ml for amphotericin B.Discussion The successful construction of the bone invasion model of A. fumigatus has provided a solid basis for future investigations into the mechanisms underlying A. fumigatus bone invasion and the study of its virulence factors. Utilizing bone models is of utmost importance in advancing the development of novel antifungal treatment approaches, as well as in effectively preventing and treating fungal bone invasion and osteolytic diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Keratomycosis caused by Aspergillus viridinutans: an Aspergillus fumigatus-resembling mold presenting distinct clinical and antifungal susceptibility patterns
    Shigeyasu, Chika
    Yamada, Masakazu
    Nakamura, Natsuko
    Mizuno, Yoshinobu
    Sato, Tomotaka
    Yaguchi, Takashi
    MEDICAL MYCOLOGY, 2012, 50 (05) : 525 - 528
  • [32] Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses
    Yasemin Öz
    Havva Gül Özdemir
    Egemen Gökbolat
    Nuri Kiraz
    Macit Ilkit
    Seyedmojtaba Seyedmousavi
    Mycopathologia, 2016, 181 : 225 - 233
  • [33] Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses
    Oz, Yasemin
    Ozdemir, Havva Gul
    Gokbolat, Egemen
    Kiraz, Nuri
    Ilkit, Macit
    Seyedmousavi, Seyedmojtaba
    MYCOPATHOLOGIA, 2016, 181 (3-4) : 225 - 233
  • [34] Antifungal Effect of All-trans Retinoic Acid against Aspergillus fumigatus In Vitro and in a Pulmonary Aspergillosis In Vivo Model
    Campione, Elena
    Gaziano, Roberta
    Doldo, Elena
    Marino, Daniele
    Falconi, Mattia
    Iacovelli, Federico
    Tagliaferri, Daniela
    Pacello, Lucrezia
    Bianchi, Luca
    Lanna, Caterina
    Aurisicchio, Luigi
    Centofanti, Federica
    Di Francesco, Paolo
    Del Principe, Ilaria
    Del Bufalo, Francesca
    Locatelli, Franco
    Pistoia, Enrico Salvatore
    Marra, Emanuele
    Orlandi, Augusto
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
  • [35] Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two In Vitro Methods
    Lyskova, Pavlina
    Hubka, Vit
    Svobodova, Lucie
    Barrs, Vanessa
    Dhand, Navneet K.
    Yaguchi, Takashi
    Matsuzawa, Tetsuhiro
    Horie, Yoshikazu
    Kolarik, Miroslav
    Dobias, Radim
    Hamal, Petr
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [36] Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
    Siopi, Maria
    Mavridou, Eleftheria
    Mouton, Johan W.
    Verweij, Paul E.
    Zerva, Loukia
    Meletiadis, Joseph
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) : 1611 - 1619
  • [37] Aspergillus fumigatus biofilm formation on different bone substitutes used in maxillary sinus augmentation: an in vitro analysis
    Claudio Stacchi
    Veronica Del Lupo
    Federico Berton
    Teresa Lombardi
    Raffaela Bressan
    Roberto Di Lenarda
    Cristina Lagatolla
    International Journal of Implant Dentistry, 5
  • [38] Aspergillus fumigatus biofilm formation on different bone substitutes used in maxillary sinus augmentation: an in vitro analysis
    Stacchi, Claudio
    Del Lupo, Veronica
    Berton, Federico
    Lombardi, Teresa
    Bressan, Raffaela
    Di Lenarda, Roberto
    Lagatolla, Cristina
    INTERNATIONAL JOURNAL OF IMPLANT DENTISTRY, 2019, 5 (1)
  • [39] In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates
    Jemel, Sana
    Raveloarisaona, Yannick
    Bidaud, Anne-Laure
    Djenontin, Elie
    Kallel, Aicha
    Guillot, Jacques
    Kallel, Kalthoum
    Botterel, Francoise
    Dannaoui, Eric
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [40] In Vitro Analyses of Mild Heat Stress in Combination with Antifungal Agents against Aspergillus fumigatus Biofilm
    Zeng, Rong
    Li, Min
    Chen, Qing
    Wang, Le
    Zhan, Ping
    Wang, Chong
    Lv, Guixia
    Shen, Yongnian
    Liu, Weida
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1443 - 1450